Matches in Nanopublications for { ?s ?p "[TP53 mutations reduce the prostate cancer (PCa) -free survival time in patients with needle biopsy of the prostate and primary benign diagnosis; Exon 6 mutations enhance the risk of being affected by PCa 32-fold]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[TP53 mutations reduce the prostate cancer (PCa) -free survival time in patients with needle biopsy of the prostate and primary benign diagnosis; Exon 6 mutations enhance the risk of being affected by PCa 32-fold]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP167034.RAPaDPjZq-OjxqO-aM8eeccVHqzb0RxFwOS_6ghz-t21A130_assertion description "[TP53 mutations reduce the prostate cancer (PCa) -free survival time in patients with needle biopsy of the prostate and primary benign diagnosis; Exon 6 mutations enhance the risk of being affected by PCa 32-fold]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167034.RAPaDPjZq-OjxqO-aM8eeccVHqzb0RxFwOS_6ghz-t21A130_provenance.